Reproducibility of serum insulin and glucose infusion rate profiles of insulin glargine compared with NPH insulin and insulin ultralente

被引：0
|
作者：
Scholtz, HE
Becker, RHA
机构：
来源：
DIABETES | 2004年 / 53卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A481 / A481
页数：1
相关论文
共 50 条
  • [41] Cost-utility analysis of insulin glargine compared with NPH insulin in patients with type 1 diabetes in Spain
    Terrés, CR
    Rodríguez, J
    Bolinder, B
    De Pablos, P
    DIABETES, 2004, 53 : A291 - A292
  • [42] Randomized, controlled clinical trial of glargine insulin versus ultralente insulin in type 1 diabetes
    Kudva, Y
    Basu, A
    Jenkins, G
    Pons, G
    Quandt, L
    Gebel, J
    Vogelsang, D
    Smith, S
    Isley, W
    Rizza, R
    DIABETES, 2004, 53 : A133 - A133
  • [43] Quality of life is improved with insulin glargine plus lispro compared with NPH insulin plus regular human insulin in patients with Type 1 diabetes
    Witthaus, E
    Johnston, P
    Bradley, C
    DIABETOLOGIA, 2004, 47 : A306 - A306
  • [44] Nocturnal glucose variability in patients using bedtime glargine and NPH insulin
    Mackowiak, L
    JaBlonka, E
    Broderick, O
    Goodman, G
    DIABETES, 2003, 52 : A126 - A126
  • [45] HUMAN ULTRALENTE INSULIN
    CLEUR, KA
    BRITISH MEDICAL JOURNAL, 1984, 288 (6423): : 1090 - 1090
  • [46] Hypoglycemia and postprandial glucose are lower with insulin glargine versus NPH insulin in older type 2 diabetes patients
    Fritsche, A
    Dailey, G
    Lin, Z
    Murray, F
    Häring, H
    Rosenstock, J
    GERONTOLOGIST, 2004, 44 : 221 - 221
  • [47] Comparison of fasting capillary glucose variability between insulin glargine and NPH
    Mu, Panwei
    Lu, Hongyun
    Zhang, Guochao
    Chen, Yanming
    Fu, Jingyi
    Wang, Manman
    Shu, Jiong
    Zeng, Longyi
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2011, 91 (01) : E4 - E7
  • [48] Comparison of the pharmacokinetic and pharmacodynamic profiles of insulin degludec and insulin glargine
    Heise, Tim
    Hoevelmann, Ulrike
    Nosek, Leszek
    Hermanski, Lidia
    Boucher, Susanne G.
    Haahr, Hanne
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2015, 11 (08) : 1193 - 1201
  • [49] Mixing insulin lispro and ultralente insulin - Reply
    Bolli, GB
    Torlone, E
    DIABETES CARE, 1997, 20 (06) : 1048 - 1048
  • [50] Insulin detemir provides superior glycaemic control compared with NPH insulin
    Larsen, J. J.
    Heller, S.
    Pedersen, C. B.
    DIABETOLOGIA, 2007, 50 : S393 - S394
12345